Global Non-Invasive Cancer Diagnostics Market Research Report 2026(Status and Outlook)

May 2026 | 146 pages | ID: N079DE66EBEFEN
Bosson Research

Abstracts

Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer. Moreover, increasing prevalence of cancer because of rising aging population and unhealthy lifestyle is also important factor that is fueling the growth of this market. Commercialization of non invasive cancer diagnostics and technologies is expected to grow owing to completion of human genome project (HGP) which will help in identifying chemical base pairs which make up DNA, hence opening avenues for market players. Rising awareness amongst people about the advantages of early diagnosis and treatment of cancer has led to a hike in number of people undergoing diagnosis. Furthermore, growing research and development in cancer diagnosis and treatment is another factor that is boosting the growth. Advancements in cancer detection technologies like cancer biomarkers and fluorescence in situ hybridization (FISH) technique are also expected to contribute towards the growth of this market. The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Breast cancer held the largest share in 2014 owing to factor such as increasing incidence of breast cancer. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment. Also, government and non-government organization’s (NGO) initiatives to create awareness about breast cancer early diagnosis and treatment are also helping to grow this market. Breast cancer segment is also expected to witness lucrative growth over the coming seven years as a consequence of advancements like lumpectomy and partial mastectomy. Based on technology the market is segmented into immunochemistry, molecular diagnosis and clinical chemistry. Molecular diagnostic market held the largest share in 2014 as a consequence of various advantages associated to it. These advantages include high precision of diagnosis such as high specificity, high sensitivity, and rapid turnaround time.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Non-Invasive Cancer Diagnostics market size was estimated at USD 120410.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.90% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Non-Invasive Cancer Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Non-Invasive Cancer Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Non-Invasive Cancer Diagnostics market.

Global Non-Invasive Cancer Diagnostics Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Gen-Probe Inc
• Digene Corporation
• Quest Diagnostics Inc
• Cancer, Genetics Inc
• BIOVIEW Inc
• AVIVA Biosciences Corporation
• Laboratory Corporation of America Holdings (LabCorp)
• A&G Pharmaceutical
• Affymetrix Inc
• Precision Therapeutics

Market Segmentation (by Type)

• CTCs
• CTNAS
• Exosomes

Market Segmentation (by Application)

• Blood
• Urine
• Saliva

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Non-Invasive Cancer Diagnostics Market

Overview of the regional outlook of the Non-Invasive Cancer Diagnostics Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-Invasive Cancer Diagnostics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Non-Invasive Cancer Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Non-Invasive Cancer Diagnostics
1.2 Key Market Segments
  1.2.1 Non-Invasive Cancer Diagnostics Segment by Type
  1.2.2 Non-Invasive Cancer Diagnostics Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 NON-INVASIVE CANCER DIAGNOSTICS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Non-Invasive Cancer Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Non-Invasive Cancer Diagnostics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 NON-INVASIVE CANCER DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Non-Invasive Cancer Diagnostics Product Life Cycle
3.3 Global Non-Invasive Cancer Diagnostics Sales by Manufacturers (2020-2025)
3.4 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Manufacturers (2020-2025)
3.5 Non-Invasive Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Non-Invasive Cancer Diagnostics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Non-Invasive Cancer Diagnostics Market Competitive Situation and Trends
  3.8.1 Non-Invasive Cancer Diagnostics Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Non-Invasive Cancer Diagnostics Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 NON-INVASIVE CANCER DIAGNOSTICS INDUSTRY CHAIN ANALYSIS

4.1 Non-Invasive Cancer Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF NON-INVASIVE CANCER DIAGNOSTICS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Non-Invasive Cancer Diagnostics Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Non-Invasive Cancer Diagnostics Market
5.7 ESG Ratings of Leading Companies

6 NON-INVASIVE CANCER DIAGNOSTICS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-Invasive Cancer Diagnostics Sales Market Share by Type (2020-2025)
6.3 Global Non-Invasive Cancer Diagnostics Market Size by Type (2020-2025)
6.4 Global Non-Invasive Cancer Diagnostics Price by Type (2020-2025)

7 NON-INVASIVE CANCER DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-Invasive Cancer Diagnostics Market Sales by Application (2020-2025)
7.3 Global Non-Invasive Cancer Diagnostics Market Size (M USD) by Application (2020-2025)
7.4 Global Non-Invasive Cancer Diagnostics Sales Growth Rate by Application (2020-2025)

8 NON-INVASIVE CANCER DIAGNOSTICS MARKET SALES BY REGION

8.1 Global Non-Invasive Cancer Diagnostics Sales by Region
  8.1.1 Global Non-Invasive Cancer Diagnostics Sales by Region
  8.1.2 Global Non-Invasive Cancer Diagnostics Sales Market Share by Region
8.2 Global Non-Invasive Cancer Diagnostics Market Size by Region
  8.2.1 Global Non-Invasive Cancer Diagnostics Market Size by Region
  8.2.2 Global Non-Invasive Cancer Diagnostics Market Size by Region
8.3 North America
  8.3.1 North America Non-Invasive Cancer Diagnostics Sales by Country
  8.3.2 North America Non-Invasive Cancer Diagnostics Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Non-Invasive Cancer Diagnostics Sales by Country
  8.4.2 Europe Non-Invasive Cancer Diagnostics Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Non-Invasive Cancer Diagnostics Sales by Region
  8.5.2 Asia Pacific Non-Invasive Cancer Diagnostics Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Non-Invasive Cancer Diagnostics Sales by Country
  8.6.2 South America Non-Invasive Cancer Diagnostics Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Non-Invasive Cancer Diagnostics Sales by Region
  8.7.2 Middle East and Africa Non-Invasive Cancer Diagnostics Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 NON-INVASIVE CANCER DIAGNOSTICS MARKET PRODUCTION BY REGION

9.1 Global Production of Non-Invasive Cancer Diagnostics by Region(2020-2025)
9.2 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Region (2020-2025)
9.3 Global Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Non-Invasive Cancer Diagnostics Production
  9.4.1 North America Non-Invasive Cancer Diagnostics Production Growth Rate (2020-2025)
  9.4.2 North America Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Non-Invasive Cancer Diagnostics Production
  9.5.1 Europe Non-Invasive Cancer Diagnostics Production Growth Rate (2020-2025)
  9.5.2 Europe Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Non-Invasive Cancer Diagnostics Production (2020-2025)
  9.6.1 Japan Non-Invasive Cancer Diagnostics Production Growth Rate (2020-2025)
  9.6.2 Japan Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Non-Invasive Cancer Diagnostics Production (2020-2025)
  9.7.1 China Non-Invasive Cancer Diagnostics Production Growth Rate (2020-2025)
  9.7.2 China Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Gen-Probe Inc
  10.1.1 Gen-Probe Inc Basic Information
  10.1.2 Gen-Probe Inc Non-Invasive Cancer Diagnostics Product Overview
  10.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Product Market Performance
  10.1.4 Gen-Probe Inc Business Overview
  10.1.5 Gen-Probe Inc SWOT Analysis
  10.1.6 Gen-Probe Inc Recent Developments
10.2 Digene Corporation
  10.2.1 Digene Corporation Basic Information
  10.2.2 Digene Corporation Non-Invasive Cancer Diagnostics Product Overview
  10.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Product Market Performance
  10.2.4 Digene Corporation Business Overview
  10.2.5 Digene Corporation SWOT Analysis
  10.2.6 Digene Corporation Recent Developments
10.3 Quest Diagnostics Inc
  10.3.1 Quest Diagnostics Inc Basic Information
  10.3.2 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Product Overview
  10.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Product Market Performance
  10.3.4 Quest Diagnostics Inc Business Overview
  10.3.5 Quest Diagnostics Inc SWOT Analysis
  10.3.6 Quest Diagnostics Inc Recent Developments
10.4 Cancer, Genetics Inc
  10.4.1 Cancer, Genetics Inc Basic Information
  10.4.2 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Product Overview
  10.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Product Market Performance
  10.4.4 Cancer, Genetics Inc Business Overview
  10.4.5 Cancer, Genetics Inc Recent Developments
10.5 BIOVIEW Inc
  10.5.1 BIOVIEW Inc Basic Information
  10.5.2 BIOVIEW Inc Non-Invasive Cancer Diagnostics Product Overview
  10.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Product Market Performance
  10.5.4 BIOVIEW Inc Business Overview
  10.5.5 BIOVIEW Inc Recent Developments
10.6 AVIVA Biosciences Corporation
  10.6.1 AVIVA Biosciences Corporation Basic Information
  10.6.2 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Product Overview
  10.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Product Market Performance
  10.6.4 AVIVA Biosciences Corporation Business Overview
  10.6.5 AVIVA Biosciences Corporation Recent Developments
10.7 Laboratory Corporation of America Holdings (LabCorp)
  10.7.1 Laboratory Corporation of America Holdings (LabCorp) Basic Information
  10.7.2 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Product Overview
  10.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Product Market Performance
  10.7.4 Laboratory Corporation of America Holdings (LabCorp) Business Overview
  10.7.5 Laboratory Corporation of America Holdings (LabCorp) Recent Developments
10.8 AandG Pharmaceutical
  10.8.1 AandG Pharmaceutical Basic Information
  10.8.2 AandG Pharmaceutical Non-Invasive Cancer Diagnostics Product Overview
  10.8.3 AandG Pharmaceutical Non-Invasive Cancer Diagnostics Product Market Performance
  10.8.4 AandG Pharmaceutical Business Overview
  10.8.5 AandG Pharmaceutical Recent Developments
10.9 Affymetrix Inc
  10.9.1 Affymetrix Inc Basic Information
  10.9.2 Affymetrix Inc Non-Invasive Cancer Diagnostics Product Overview
  10.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Product Market Performance
  10.9.4 Affymetrix Inc Business Overview
  10.9.5 Affymetrix Inc Recent Developments
10.10 Precision Therapeutics
  10.10.1 Precision Therapeutics Basic Information
  10.10.2 Precision Therapeutics Non-Invasive Cancer Diagnostics Product Overview
  10.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Product Market Performance
  10.10.4 Precision Therapeutics Business Overview
  10.10.5 Precision Therapeutics Recent Developments

11 NON-INVASIVE CANCER DIAGNOSTICS MARKET FORECAST BY REGION

11.1 Global Non-Invasive Cancer Diagnostics Market Size Forecast
11.2 Global Non-Invasive Cancer Diagnostics Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Non-Invasive Cancer Diagnostics Market Size Forecast by Country
  11.2.3 Asia Pacific Non-Invasive Cancer Diagnostics Market Size Forecast by Region
  11.2.4 South America Non-Invasive Cancer Diagnostics Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Non-Invasive Cancer Diagnostics by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Non-Invasive Cancer Diagnostics Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Non-Invasive Cancer Diagnostics by Type (2026-2035)
  12.1.2 Global Non-Invasive Cancer Diagnostics Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Non-Invasive Cancer Diagnostics by Type (2026-2035)
12.2 Global Non-Invasive Cancer Diagnostics Market Forecast by Application (2026-2035)
  12.2.1 Global Non-Invasive Cancer Diagnostics Sales (K Units) Forecast by Application
  12.2.2 Global Non-Invasive Cancer Diagnostics Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Non-Invasive Cancer Diagnostics Market Size by Type (M USD)
Table 4. Global Non-Invasive Cancer Diagnostics Market Size by Application
Table 5. Non-Invasive Cancer Diagnostics Market Size Comparison by Region (M USD)
Table 6. Global Non-Invasive Cancer Diagnostics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Non-Invasive Cancer Diagnostics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Non-Invasive Cancer Diagnostics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Non-Invasive Cancer Diagnostics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Cancer Diagnostics as of 2025)
Table 11. Global Market Non-Invasive Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Non-Invasive Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non-Invasive Cancer Diagnostics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Non-Invasive Cancer Diagnostics Sales by Type (K Units)
Table 27. Global Non-Invasive Cancer Diagnostics Market Size by Type (M USD)
Table 28. Global Non-Invasive Cancer Diagnostics Sales (K Units) by Type (2020-2025)
Table 29. Global Non-Invasive Cancer Diagnostics Sales Market Share by Type (2020-2025)
Table 30. Global Non-Invasive Cancer Diagnostics Market Size (M USD) by Type (2020-2025)
Table 31. Global Non-Invasive Cancer Diagnostics Market Share by Type (2020-2025)
Table 32. Global Non-Invasive Cancer Diagnostics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Non-Invasive Cancer Diagnostics Sales (K Units) by Application
Table 34. Global Non-Invasive Cancer Diagnostics Market Size by Application
Table 35. Global Non-Invasive Cancer Diagnostics Sales by Application (2020-2025) & (K Units)
Table 36. Global Non-Invasive Cancer Diagnostics Sales Market Share by Application (2020-2025)
Table 37. Global Non-Invasive Cancer Diagnostics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Non-Invasive Cancer Diagnostics Market Share by Application (2020-2025)
Table 39. Global Non-Invasive Cancer Diagnostics Sales Growth Rate by Application (2020-2025)
Table 40. Global Non-Invasive Cancer Diagnostics Sales by Region (2020-2025) & (K Units)
Table 41. Global Non-Invasive Cancer Diagnostics Sales Market Share by Region (2020-2025)
Table 42. Global Non-Invasive Cancer Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Non-Invasive Cancer Diagnostics Market Size by Region (2020-2025)
Table 44. North America Non-Invasive Cancer Diagnostics Sales by Country (2020-2025) & (K Units)
Table 45. North America Non-Invasive Cancer Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Non-Invasive Cancer Diagnostics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Non-Invasive Cancer Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Non-Invasive Cancer Diagnostics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Non-Invasive Cancer Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Non-Invasive Cancer Diagnostics Sales by Country (2020-2025) & (K Units)
Table 51. South America Non-Invasive Cancer Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Non-Invasive Cancer Diagnostics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Non-Invasive Cancer Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Non-Invasive Cancer Diagnostics Production (K Units) by Region(2020-2025)
Table 55. Global Non-Invasive Cancer Diagnostics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Non-Invasive Cancer Diagnostics Revenue Market Share by Region (2020-2025)
Table 57. Global Non-Invasive Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Non-Invasive Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Non-Invasive Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Non-Invasive Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Non-Invasive Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Gen-Probe Inc Basic Information
Table 63. Gen-Probe Inc Non-Invasive Cancer Diagnostics Product Overview
Table 64. Gen-Probe Inc Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Gen-Probe Inc Business Overview
Table 66. Gen-Probe Inc SWOT Analysis
Table 67. Gen-Probe Inc Recent Developments
Table 68. Digene Corporation Basic Information
Table 69. Digene Corporation Non-Invasive Cancer Diagnostics Product Overview
Table 70. Digene Corporation Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Digene Corporation Business Overview
Table 72. Digene Corporation SWOT Analysis
Table 73. Digene Corporation Recent Developments
Table 74. Quest Diagnostics Inc Basic Information
Table 75. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Product Overview
Table 76. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Quest Diagnostics Inc Business Overview
Table 78. Quest Diagnostics Inc SWOT Analysis
Table 79. Quest Diagnostics Inc Recent Developments
Table 80. Cancer, Genetics Inc Basic Information
Table 81. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Product Overview
Table 82. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Cancer, Genetics Inc Business Overview
Table 84. Cancer, Genetics Inc Recent Developments
Table 85. BIOVIEW Inc Basic Information
Table 86. BIOVIEW Inc Non-Invasive Cancer Diagnostics Product Overview
Table 87. BIOVIEW Inc Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. BIOVIEW Inc Business Overview
Table 89. BIOVIEW Inc Recent Developments
Table 90. AVIVA Biosciences Corporation Basic Information
Table 91. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Product Overview
Table 92. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. AVIVA Biosciences Corporation Business Overview
Table 94. AVIVA Biosciences Corporation Recent Developments
Table 95. Laboratory Corporation of America Holdings (LabCorp) Basic Information
Table 96. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Product Overview
Table 97. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Laboratory Corporation of America Holdings (LabCorp) Business Overview
Table 99. Laboratory Corporation of America Holdings (LabCorp) Recent Developments
Table 100. AandG Pharmaceutical Basic Information
Table 101. AandG Pharmaceutical Non-Invasive Cancer Diagnostics Product Overview
Table 102. AandG Pharmaceutical Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. AandG Pharmaceutical Business Overview
Table 104. AandG Pharmaceutical Recent Developments
Table 105. Affymetrix Inc Basic Information
Table 106. Affymetrix Inc Non-Invasive Cancer Diagnostics Product Overview
Table 107. Affymetrix Inc Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Affymetrix Inc Business Overview
Table 109. Affymetrix Inc Recent Developments
Table 110. Precision Therapeutics Basic Information
Table 111. Precision Therapeutics Non-Invasive Cancer Diagnostics Product Overview
Table 112. Precision Therapeutics Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Precision Therapeutics Business Overview
Table 114. Precision Therapeutics Recent Developments
Table 115. Global Non-Invasive Cancer Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 116. Global Non-Invasive Cancer Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Non-Invasive Cancer Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 118. North America Non-Invasive Cancer Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Non-Invasive Cancer Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 120. Europe Non-Invasive Cancer Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Non-Invasive Cancer Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 122. Asia Pacific Non-Invasive Cancer Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Non-Invasive Cancer Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 124. South America Non-Invasive Cancer Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Non-Invasive Cancer Diagnostics Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Non-Invasive Cancer Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Non-Invasive Cancer Diagnostics Sales Forecast by Type (2026-2035) & (K Units)
Table 128. Global Non-Invasive Cancer Diagnostics Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Non-Invasive Cancer Diagnostics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 130. Global Non-Invasive Cancer Diagnostics Sales (K Units) Forecast by Application (2026-2035)
Table 131. Global Non-Invasive Cancer Diagnostics Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Non-Invasive Cancer Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-Invasive Cancer Diagnostics Market Size (M USD), 2025-2035
Figure 5. Global Non-Invasive Cancer Diagnostics Market Size (M USD) (2020-2035)
Figure 6. Global Non-Invasive Cancer Diagnostics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non-Invasive Cancer Diagnostics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Non-Invasive Cancer Diagnostics Product Life Cycle
Figure 13. Non-Invasive Cancer Diagnostics Sales Share by Manufacturers in 2025
Figure 14. Global Non-Invasive Cancer Diagnostics Revenue Share by Manufacturers in 2025
Figure 15. Non-Invasive Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Non-Invasive Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Non-Invasive Cancer Diagnostics Revenue in 2025
Figure 18. Industry Chain Map of Non-Invasive Cancer Diagnostics
Figure 19. Global Non-Invasive Cancer Diagnostics Market PEST Analysis
Figure 20. Global Non-Invasive Cancer Diagnostics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Non-Invasive Cancer Diagnostics Market Share by Type
Figure 27. Sales Market Share of Non-Invasive Cancer Diagnostics by Type (2020-2025)
Figure 28. Sales Market Share of Non-Invasive Cancer Diagnostics by Type in 2025
Figure 29. Market Share of Non-Invasive Cancer Diagnostics by Type (2020-2025)
Figure 30. Market Share of Non-Invasive Cancer Diagnostics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Non-Invasive Cancer Diagnostics Market Share by Application
Figure 33. Global Non-Invasive Cancer Diagnostics Sales Market Share by Application (2020-2025)
Figure 34. Global Non-Invasive Cancer Diagnostics Sales Market Share by Application in 2025
Figure 35. Global Non-Invasive Cancer Diagnostics Market Share by Application (2020-2025)
Figure 36. Global Non-Invasive Cancer Diagnostics Market Share by Application in 2025
Figure 37. Global Non-Invasive Cancer Diagnostics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Non-Invasive Cancer Diagnostics Sales Market Share by Region (2020-2025)
Figure 39. Global Non-Invasive Cancer Diagnostics Market Size by Region (2020-2025)
Figure 40. North America Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Non-Invasive Cancer Diagnostics Sales Market Share by Country in 2024
Figure 43. North America Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Non-Invasive Cancer Diagnostics Market Size by Country in 2024
Figure 45. U.S. Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Non-Invasive Cancer Diagnostics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Non-Invasive Cancer Diagnostics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Non-Invasive Cancer Diagnostics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Non-Invasive Cancer Diagnostics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Non-Invasive Cancer Diagnostics Sales Market Share by Country in 2024
Figure 53. Europe Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Non-Invasive Cancer Diagnostics Market Size by Country in 2024
Figure 55. Germany Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Non-Invasive Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Non-Invasive Cancer Diagnostics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Non-Invasive Cancer Diagnostics Market Size by Region in 2024
Figure 68. China Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Non-Invasive Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 79. South America Non-Invasive Cancer Diagnostics Sales Market Share by Country in 2024
Figure 80. South America Non-Invasive Cancer Diagnostics Market Size and Growth Rate (M USD)
Figure 81. South America Non-Invasive Cancer Diagnostics Market Size by Country in 2024
Figure 82. Brazil Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Non-Invasive Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Non-Invasive Cancer Diagnostics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Non-Invasive Cancer Diagnostics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Non-Invasive Cancer Diagnostics Market Size by Region in 2024
Figure 92. Saudi Arabia Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Non-Invasive Cancer Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Non-Invasive Cancer Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Non-Invasive Cancer Diagnostics Production Market Share by Region (2020-2025)
Figure 103. North America Non-Invasive Cancer Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Non-Invasive Cancer Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Non-Invasive Cancer Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Non-Invasive Cancer Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Non-Invasive Cancer Diagnostics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Non-Invasive Cancer Diagnostics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Non-Invasive Cancer Diagnostics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Non-Invasive Cancer Diagnostics Market Share Forecast by Type (2026-2035)
Figure 111. Global Non-Invasive Cancer Diagnostics Sales Forecast by Application (2026-2035)
Figure 112. Global Non-Invasive Cancer Diagnostics Market Share Forecast by Application (2026-2035)